ReviewIntegrative cancer therapies2018

Evidence-Based Review of BioBran/MGN-3 Arabinoxylan Compound as a Complementary Therapy for Conventional Cancer Treatment.

Soo Liang Ooi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.